Simulations Plus

Simulations Plus, Inc | Modeling & Simulation Software | Consulting Services for Pharmaceutical Research.

Launch date

1996

Employees

Market cap

Enterprise valuation

$527m (Public information from Sep 2024)

Lancaster California (HQ)

http://simulations-plus.com

https://twitter.com/simulationsplus https://www.facebook.com/simulationsplus https://www.linkedin.com/company/simulations-plus/

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	41.6m	46.5m	53.9m	59.6m	71.0m	91.9m	89.7m
% growth	22 %	12 %	16 %	11 %	19 %	29 %	(2 %)
EBITDA	11.9m	11.5m	14.9m	8.7m	23.7m	28.2m	-
% EBITDA margin	28 %	25 %	28 %	15 %	33 %	31 %	-
Profit	9.3m	9.8m	12.5m	10.0m	13.3m	16.6m	-
% profit margin	22 %	21 %	23 %	17 %	19 %	18 %	-
EV / revenue	28.1x	19.2x	22.5x	14.9x	12.8x	9.9x	10.1x
EV / EBITDA	98.6x	77.9x	81.5x	101.6x	38.3x	32.1x	-
R&D budget	3.0m	4.0m	3.2m	4.5m	-	-	-
R&D % of revenue	7 %	9 %	6 %	8 %	-	-	-

Date	Investors	Amount	Round
Jun 1997	N/A	$5.7m Valuation: $20.0m	IPO
May 2020	N/A	N/A	-
Feb 2021	Small Business Innovation Research (SBIR)	N/A	Grant
Mar 2022*	National Institutes of Health	$1.7m	Grant
Sep 2023*	US Food and Drug Administration	N/A	Grant
Mar 2024*	US Food and Drug Administration	N/A	Grant
Total Funding		$1.7m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Simulations Plus Jul 2014

ACQUISITION by Simulations Plus Jun 2023

DILIsym Services

ACQUISITION by Simulations Plus May 2017

ACQUISITION by Simulations Plus Apr 2020

ACQUISITION by Simulations Plus Jun 2024